Aricept Approved In Japan As Treatment For Dementia With Lewy Bodies
Tokyo, Sept 19, 2014 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that its anti-Alzheimer's agent Aricept (donepezil hydrochloride) has received approval for a new indication for dementia with Lewy bodies (DLB) in Japan. DLB is considered to be one of Japan's three major types of dementia, alongside Alzheimer's disease and vascular dementia.
The Reality Of Heart Disease: A Wake-Up Call For Women
In a timely opinion piece in The New York Times Sunday Review, “A Woman’s Heart Attack,” (September 28) Martha Weinman Lear eloquently describes her own journey of self education and a newly found awareness after experiencing what her own physician believes may be a viral syndrome, not recognizing the often subtle symptoms of a heart attack--which included nausea and vomiting, chest pressure ...
World Heart Day
World Heart Federation is getting together with UN to try and curb heart disease.
Researchers define spontaneous retinal neovascular mouse model
Researchers have characterized a novel mutant mouse model, termed neoretinal vascularization 2, which develops abnormal neovessels from retinal vascular plexus. Their hope is this new model will help them understand AMD and develop new treatments for the disease.
LeMaitre Vascular Acquires Angioscope
BURLINGTON, Mass. -- LeMaitre Vascular, Inc. , a provider of peripheral vascular devices and implants, announced today that on September 17, 2014 it acquired the angioscope product line from Applied Medical, ...
A glass of milk daily is good for your heart
The link between milk and risk for hyper-tension and cardio-vascular disease (CVD) was examined in a study recently presented at the 12th Euro Fed Lipid Congress in Montpellier, France.